PON1 and inherited lipid metabolism disorder: Our study shows multifaceted associations of PON1 with dyslipidaemia, ICS, and cardiovascular mortality in HD patients providing arguments for the consideration of PON1 as a therapeutic target in the prevention of atherosclerosis and its complications in uremic patients.